BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 2 , Pages 88-92, April 2009

Decreasing procedural pain over time of left prefrontal rtms for depression: Initial results from the open-label phase of a multisite trial (OPT-TMS)

  • Berry S. Anderson, PhD(c), RN

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina
    • Corresponding Author InformationCorrespondence: Mr. Berry S. Anderson, 502 N, Institute of Psychiatry, 67 President St, Charleston, SC, 29425.
  • ,
  • Katie Kavanagh

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Jeffrey J. Borckardt, PhD

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Ziad H. Nahas, MD

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Samet Kose, MD

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina
  • ,
  • Sarah H. Lisanby, MD

      Affiliations

    • Brain Stimulation and Therapeutic Neuromodulation, New York State Psychiatric Institute, and Columbia University, New York, New York
  • ,
  • William M. McDonald, MD

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia
  • ,
  • David Avery, MD

      Affiliations

    • Psychiatry Department, University of Washington School of Medicine, Seattle, Washington
  • ,
  • Harold A. Sackeim, PhD

      Affiliations

    • Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York
  • ,
  • Mark S. George, MD

      Affiliations

    • Brain Stimulation Laboratory, Psychiatry Department, Medical University of South Carolina, Charleston, South Carolina

Received 23 January 2008; received in revised form 11 August 2008; accepted 2 September 2008. published online 11 December 2008.

Background

There is much interest in whether daily left prefrontal repetitive transcranial magnetic stimulation (rTMS) over several weeks may become a clinically useful antidepressant treatment. Although rTMS appears largely safe, many patients report that this procedure is somewhat painful, which may restrict its ultimate appeal and use. We analyzed interim results from the open-label phase of a multisite randomized trial of rTMS as a treatment for depression to investigate whether the procedural pain of left prefrontal rTMS changes over time.

Methods

Patients with unipolar depression who had failed to respond during at least 3 weeks of the sham-controlled double-masked rTMS were then offered 3 more weeks (15 sessions) of open-label rTMS. Retrospective pain ratings and state emotional factors from 20 subjects were assessed with the use of visual analog scales (VAS) recorded on computers before and after each treatment (289 sessions).

Results

Over the 15 treatment sessions, subjective reports of the painfulness of rTMS decreased 48% from baseline. This reduction, although greatest in the first few days, continued steadily (average 2.11 points per session) over the 3 weeks of treatment. The analysis found a significant effect for rTMS-session (P < .0001) on rTMS-procedural pain over and above changes in subjective emotional states.

Conclusions

The procedural pain of left, prefrontal rTMS decreases over time, apparently independently of other emotional changes. Because rTMS scalp pain may decline over time, physicians and patients may decide to continue treatment despite initial discomfort. These observational data can be better tested once the data from the blinded phase of the trial becomes available.

Keywords: transcranial magnetic stimulation, pain, discomfort, virtual analog scale

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The study was funded by National Institute of Mental Health (NIMH) Grants R01MH069887, R01MH069896, R01MH069895, R01MH069886, and R01MH069929; and equipment support was provided by Neuronetics, Inc. Additional support for the MUSC Brain Stimulation Laboratory comes from the Stanley Foundation, the National Alliance for Research on Schizophrenia and Depression (NARSAD), NIMH Grant K08MH070615 (Dr Nahas), and NINDS Grant K23NS050485 (Dr Borckardt).

 Conflicts of Interest: MUSC holds several TMS-related patents. Drs George and Sackeim are advisory board members for Neuronetics, Inc.

PII: S1935-861X(08)00333-1

doi:10.1016/j.brs.2008.09.001

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 2 , Pages 88-92, April 2009